Colin Broom M.D., Director at Nabriva Therapeutics plc (NBRV), sold 531 shares at $1.20 ($637) on 2021-08-02, disclosed to the SEC on 2021-08-04.
Open-market sale of $637 NBRV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NBRV | BUY | 2019-09-03 | $21K | — | Filing → |
| NBRV | BUY | 2018-06-25 | $19K | — | Filing → |
| NBRV | BUY | 2018-05-23 | $46K | — | Filing → |